Suppression of human myelosarcoma growth in athymic mice by a primate antiserum

A primate (Macaca speciosa) antiserum prepared against the human chronic myelogenous leukemia cell line K-562 suppressed the growth of the human myelosarcomas in nude mice. The ip administration of 0.5 ml of immune serum plus 0.5 ml of guinea pig complement, starting 7 days after sc tumor transplant...

Full description

Saved in:
Bibliographic Details
Published inCancer treatment reports Vol. 61; no. 9; p. 1679
Main Authors Lozzio, B B, Machado, E A, Lair, S A, Lozzio, C B
Format Journal Article
LanguageEnglish
Published United States 01.12.1977
Subjects
Animals
Cell Division
Cell Line
Complement System Proteins
Immunization, Passive
Leukemia, Myeloid - pathology
Leukemia, Myeloid - therapy
Mice
Mice, Nude
Neoplasm Transplantation
Sarcoma, Experimental - therapy
Transplantation, Heterologous
Online AccessGet more information

Cover

More Information
Summary:A primate (Macaca speciosa) antiserum prepared against the human chronic myelogenous leukemia cell line K-562 suppressed the growth of the human myelosarcomas in nude mice. The ip administration of 0.5 ml of immune serum plus 0.5 ml of guinea pig complement, starting 7 days after sc tumor transplantation, resulted in a fourfold to fivefold decrease in tumor weight at 15 days when compared to nude mice given pre-immune serum plus complement or complement alone. Whereas the other two groups experienced an exponential increase in tumor volume at 7-9 days after tumor transplantation, the immune serum-treated mice remained in a "lag" phase of tumor growth during which the tumor volume neither increased nor decreased substantially. Histopathologic studies revealed various degrees of tumor alterations ranging form focal hydropic cellular degeneration to massive coagulation necrosis. The incorporation of tritiated thymidine into the tumors was also markedly diminished in the mice given immune serum.
ISSN:0361-5960